Online citations, reference lists, and bibliographies.
← Back to Search

A Nanomaterial-based Breath Test For Distinguishing Gastric Cancer From Benign Gastric Conditions

Z-q Xu, Y. Broza, R. Ionsecu, U. Tisch, L. Ding, H. Liu, Q. Song, Y-y Pan, F-x Xiong, K-s Gu, G-p Sun, Z-d Chen, M. Leja, H. Haick
Published 2013 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Background:Upper digestive endoscopy with biopsy and histopathological evaluation of the biopsy material is the standard method for diagnosing gastric cancer (GC). However, this procedure may not be widely available for screening in the developing world, whereas in developed countries endoscopy is frequently used without major clinical gain. There is a high demand for a simple and non-invasive test for selecting the individuals at increased risk that should undergo the endoscopic examination. Here, we studied the feasibility of a nanomaterial-based breath test for identifying GC among patients with gastric complaints.Methods:Alveolar exhaled breath samples from 130 patients with gastric complaints (37 GC/32 ulcers / 61 less severe conditions) that underwent endoscopy/biopsy were analyzed using nanomaterial-based sensors. Predictive models were built employing discriminant factor analysis (DFA) pattern recognition, and their stability against possible confounding factors (alcohol/tobacco consumption; Helicobacter pylori) was tested. Classification success was determined (i) using leave-one-out cross-validation and (ii) by randomly blinding 25% of the samples as a validation set. Complementary chemical analysis of the breath samples was performed using gas chromatography coupled with mass spectrometry.Results:Three DFA models were developed that achieved excellent discrimination between the subpopulations: (i) GC vs benign gastric conditions, among all the patients (89% sensitivity; 90% specificity); (ii) early stage GC (I and II) vs late stage (III and IV), among GC patients (89% sensitivity; 94% specificity); and (iii) ulcer vs less severe, among benign conditions (84% sensitivity; 87% specificity). The models were insensitive against the tested confounding factors. Chemical analysis found that five volatile organic compounds (2-propenenitrile, 2-butoxy-ethanol, furfural, 6-methyl-5-hepten-2-one and isoprene) were significantly elevated in patients with GC and/or peptic ulcer, as compared with less severe gastric conditions. The concentrations both in the room air and in the breath samples were in the single p.p.b.v range, except in the case of isoprene.Conclusion:The preliminary results of this pilot study could open a new and promising avenue to diagnose GC and distinguish it from other gastric diseases. It should be noted that the applied methods are complementary and the potential marker compounds identified by gas-chromatography/mass spectrometry are not necessarily responsible for the differences in the sensor responses. Although this pilot study does not allow drawing far-reaching conclusions, the encouraging preliminary results presented here have initiated a large multicentre clinical trial to confirm the observed patterns for GC and benign gastric conditions.
This paper references
10.32388/pfg7jq
International agency for research on cancer.
J. Higginson (1974)
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]
J. Ferlay (2013)
10.1186/1471-2407-9-348
Noninvasive detection of lung cancer by analysis of exhaled breath
A. Bajtarevic (2009)
10.1039/b205009a
Quantitative analysis of NO2 in the presence of CO using a single tungsten oxide semiconductor sensor and dynamic signal processing.
R. Ionescu (2002)
10.1007/s10120-006-0399-y
Detection of early gastric cancer: misunderstanding the role of mass screening
H. Suzuki (2006)
10.2147/IJN.S32680
The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)
H. Amal (2012)
10.2174/138955707779802606
Breath analysis: the approach towards clinical applications.
A. Amann (2007)
10.1007/s10120-002-0203-6
The epidemiology of gastric cancer
D. Roder (2002)
10.1038/nnano.2009.235
Diagnosing lung cancer in exhaled breath using gold nanoparticles.
G. Peng (2009)
10.1016/j.lungcan.2009.03.029
Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Geng Song (2010)
10.1016/j.cca.2010.06.005
Breath biomarkers for lung cancer detection and assessment of smoking related effects--confounding variables, influence of normalization and statistical algorithms.
S. Kischkel (2010)
10.1016/J.CCCN.2004.04.023
Diagnostic potential of breath analysis--focus on volatile organic compounds.
W. Miekisch (2004)
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc) BRITISH JOURNAL OF CANCER A breath test for gastric cancer
10.1016/0016-5085(95)90468-9
Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis.
H. Carpenter (1995)
10.1093/CLINCHEM/34.8.1613
A computerized classification technique for screening for the presence of breath biomarkers in lung cancer.
H. O'neill (1988)
10.1158/1055-9965.EPI-09-0162
TD-GC-MS Analysis of Volatile Metabolites of Human Lung Cancer and Normal Cells In vitro
W. Filipiak (2010)
v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer: Lyon, France, available at http://globocaniarcfr (accessed on
J Ferlay (2010)
CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
M. Carpelan-Holmström (2002)
2010c) Sensors based on monolayer-capped metal nanoparticles
U Tisch (2010)
10.1001/ARCHSURG.1983.01390060092027
Cancer: Principles and Practice of Oncology
G. Steele (1983)
Detection of early
H Suzuki (2006)
10.1016/j.nano.2012.07.009
A nanomaterial-based breath test for short-term follow-up after lung tumor resection.
Y. Broza (2013)
10.1111/j.1440-1746.1991.tb01469.x
The Sydney System: Endoscopic division. Endoscopic appearances in gastritis/duodenitis
G. Tytgat (1991)
GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No
J Ferlay (2010)
Cancer of the stomach. In: DeVita VT, Lawrence TS, Rosenberg SA (eds) 8th edn). DeVita, Hellman, and Rosenberg’s
PT Pisters (2008)
10.1007/978-1-349-10415-4
Cancer of the stomach.
J. C. Paymaster (1973)
10.1021/cr300174a
Volatile organic compounds of lung cancer and possible biochemical pathways.
M. Hakim (2012)
Cancer of the stomach.
L. Simon (1951)
10.1183/1025448X.00018509
Methodological issues of sample collection and analysis of exhaled breath
A. Amann (2010)
10.1515/revce.2010.009
Arrays of chemisensitive monolayer-capped metallic nanoparticles for diagnostic breath testing
U. Tisch (2010)
10.1128/AAC.00016-11
Cholesterol Enhances Helicobacter pylori Resistance to Antibiotics and LL-37
D. J. McGee (2011)
10.1016/j.jtbi.2010.09.028
Physiological modeling of isoprene dynamics in exhaled breath.
J. King (2010)
10.1515/CCLM.2009.133
Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry
M. Ligor (2009)
10.1038/sj.bjc.6605810
Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors
G. Peng (2010)
10.1148/radiol.2522081249
Differentiation between malignant and benign gastric ulcers: CT virtual gastroscopy versus optical gastroendoscopy.
Chiao-Yun Chen (2009)
10.1021/cn200093r
Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors.
U. Tisch (2012)
10.1056/NEJM195604052541403
Correlation of gross gastroscopic findings with gastroscopic biopsy in gastritis.
L. Atkins (1956)
10.1093/jjco/hyn017
The Japanese guidelines for gastric cancer screening.
C. Hamashima (2008)
10.1002/14356007.A12_119.PUB2
Furfural and Derivatives
H. Hoydonckx (2007)
10.1038/bjc.2011.128
Diagnosis of head-and-neck cancer from exhaled breath
M. Hakim (2011)
10.1007/978-1-4612-4380-9_16
Individual Comparisons by Ranking Methods
F. Wilcoxon (1945)
10.1007/s10120-005-0320-0
Molecular-pathological prognostic factors of gastric cancer: a review
W. Yasui (2005)
10.1021/am2013695
Effect of humidity on nanoparticle-based chemiresistors: a comparison between synthetic and real-world samples.
Gady Konvalina (2012)
10.1093/CLINCHEM/31.8.1278
Volatile organic compounds in exhaled air from patients with lung cancer.
S. Gordon (1985)
10.1093/CLINCHEM/40.8.1485
Pentane and isoprene in expired air from humans: gas-chromatographic analysis of single breath.
S. Mendis (1994)
10.1021/cn2000603
Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes.
Radu Ionescu (2011)
Cancer Incidence and Mortality Worldwide: IARC CancerBase No
J Ferlay (2010)
10.5860/choice.26-1926
In: Ullmann''''s Encyclopedia of Industrial Chemistry
H. Hiller (1989)
10.1557/MRS2010.509
Nanomaterials for cross-reactive sensor arrays
U. Tisch (2010)
10.1021/JZ2008648
Utility of Resistance and Capacitance Response in Sensors Based on Monolayer-Capped Metal Nanoparticles
Gregory Shuster (2011)
10.1002/ijc.24970
Breath gas aldehydes as biomarkers of lung cancer
P. Fuchs (2010)
10.1016/S0140-6736(98)07552-7
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study
M. Phillips (1999)
Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, France, 17-24 February 1998.
(1999)
10.1016/J.IJMS.2007.05.012
Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas
A. Wehinger (2007)
10.1111/j.1440-1746.2008.05314.x
Asia–Pacific consensus guidelines on gastric cancer prevention
K. Fock (2008)
10.1136/JCP.47.11.1052
Metabolic and environmental origins of volatile organic compounds in breath.
M. Phillips (1994)
Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.
A. Sponring (2009)
10.7326/0003-4819-101-4-538
Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study.
C. Dooley (1984)
10.1007/s10549-010-1317-x
Classification of breast cancer precursors through exhaled breath
G. Shuster (2010)
10.1002/smll.200900937
Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles.
O. Barash (2009)
10.1016/S1470-2045(07)70246-2
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
A. Verdecchia (2007)



This paper is referenced by
10.1097/MIB.0000000000000436
Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach
A. Bodelier (2015)
10.1007/s00216-015-9200-6
Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis
Xiaohua Sun (2015)
10.2217/nnm.13.64
Nanomaterial-based sensors for detection of disease by volatile organic compounds.
Y. Broza (2013)
10.1007/978-981-13-7295-7
Biomarkers in Cancer Therapy
Hideaki Shimada (2019)
10.3748/wjg.v21.i14.4111
Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.
J. Huddy (2015)
10.1021/nl404335p
Artificial sensing intelligence with silicon nanowires for ultraselective detection in the gas phase.
Bin Wang (2014)
Non-invasive diagnosis of human diseases by combining breath analysis and neural network modeling
Juan Carlos Cancilla Buenache (2016)
10.1021/acsnano.6b03127
Silicon Nanowire Sensors Enable Diagnosis of Patients via Exhaled Breath.
Nisreen Shehada (2016)
10.1016/j.jpba.2019.113055
Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
N. De Vietro (2019)
10.1021/acschemneuro.7b00318
Altered Volatile Organic Compound Profile in Transgenic Rats Bearing A53T Mutation of Human α-Synuclein: Comparison with Dopaminergic and Serotonergic Denervation.
J. Finberg (2018)
Volatile organic compound and microbiome profiling in patients with colorectal cancer, their spouses and first degree relatives
Michael Mcfarlane (2017)
10.1007/978-981-13-7295-7_6
Specifics 1: Head and Neck Cancer and Esophageal Cancer
Shuhei Ito (2019)
10.18632/oncotarget.25331
Exhaled breath analysis for gastric cancer diagnosis in Colombian patients
C. Durán-Acevedo (2018)
10.1007/978-981-15-4431-6
Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers
Ganji Purnachandra Nagaraju (2020)
10.1371/journal.pone.0075274
Detection of an Extended Human Volatome with Comprehensive Two-Dimensional Gas Chromatography Time-of-Flight Mass Spectrometry
M. Phillips (2013)
10.1039/c3cs60329f
Assessment, origin, and implementation of breath volatile cancer markers.
H. Haick (2014)
10.1001/jamaoncol.2018.2815
Accuracy and Methodologic Challenges of Volatile Organic Compound–Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis
G. Hanna (2018)
10.1111/apt.15622
Volatile organic compounds in breath can serve as a non‐invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer
K. E. van Keulen (2019)
10.1007/s13167-017-0083-9
Pattern recognition for predictive, preventive, and personalized medicine in cancer
Tingting Cheng (2017)
10.1007/s13233-018-6114-0
Hierarchical Architectures of PMMA/MWNT-NH2 Particles: a Material for Enhanced Volatile Organic Compound Sensing Performance
Haitao Li (2018)
10.1097/SLA.0000000000001101
Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma
S. Kumar (2015)
10.1002/ijc.29701
Breath testing as potential colorectal cancer screening tool
H. Amal (2016)
10.1002/ADMT.201800488
Electronic Noses: From Advanced Materials to Sensors Aided with Data Processing
Wenwen Hu (2018)
10.1002/cac2.12030
Exhaled breath diagnostics of lung and gastric cancers in China using nanosensors
Alaa Gharra (2020)
10.1183/09031936.00183714
Detecting lung infections in breathprints: empty promise or next generation diagnosis of infections
H. Haick (2015)
10.1111/codi.12523
Metabolomics: a potential powerful ally in the fight against cancer
M. Di Lena (2014)
10.24054/01204211.v1.n1.2016.1940
Mecanismos y procedimientos aplicados al análisis del aliento para diagnóstico de diferentes enfermedades utilizando métodos multisensoriales
Juan Alberto Borré Lara (2016)
10.1088/1752-7163/aacbfb
Ex vivo emission of volatile organic compounds from gastric cancer and non-cancerous tissue.
Pawel Mochalski (2018)
10.1002/adma.202000060
A Transparent, Wearable Fluorescent Mouthguard for High-Sensitive Visualization and Accurate Localization of Hidden Dental Lesion Sites.
Xuemeng Li (2020)
10.2174/1381612825666191022162232
Non-invasive biodiversified sensors: A modernised screening technology for cancer.
Anjali Takke (2019)
10.3390/diagnostics5010027
Technologies for Clinical Diagnosis Using Expired Human Breath Analysis
T. L. Mathew (2015)
The State of Cancer Control in Australia 1987-2007: Changes in cancer incidence and mortality
Eleonora Feletto (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar